Oral transmucosal fentanyl citrate in the management of dyspnea crisis in cancer patients

被引：20

作者：

Benitez-Rosario, MA ^{[1
]}

Martin, AS

Feria, M

机构：

[1] Hosp La Candelaria, Palliat Care Unit, Tenerife, Spain

[2] Hosp La Candelaria, Res Unit, Tenerife, Spain

[3] Univ La Laguna, Dept Pharmacol, Tenerife, Spain

来源：

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT | 2005年 / 30卷 / 05期

关键词：

D O I：

10.1016/j.jpainsymman.2005.10.002

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

引用

页码：395 / 397

页数：3

共 6 条

[1] Breakthrough cancer pain:: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC®) and morphine sulfate immediate release (MSIR®) [J].

Coluzzi, PH ;

Schwartzberg, L ;

Conroy, JD ;

Charapata, S ;

Gay, M ;

Busch, MA ;

Chavez, J ;

Ashley, J ;

Lebo, D ;

McCracken, M ;

Portenoy, RK .

PAIN, 2001, 91 (1-2) :123-130

[2] Nebulized fentanyl citrate improves patients' perception of breathing, respiratory rate, and oxygen saturation in dyspnea [J].

Coyne, PJ ;

Viswanathan, R ;

Smith, TJ .

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2002, 23 (02) :157-160

[3] Dyspnea in cancer patients: Prevalence and associated factors [J].

Dudgeon, DJ ;

Kristjanson, L ;

Sloan, JA ;

Lertzman, M ;

Clement, K .

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2001, 21 (02) :95-102

[4] A systematic review of the use of opioids in the management of dyspnoea [J].

Jennings, AL ;

Davies, AN ;

Higgins, JPT ;

Gibbs, JSR ;

Broadley, KE .

THORAX, 2002, 57 (11) :939-944

[5] PALLIATION OF SYMPTOMS IN NONSMALL CELL LUNG-CANCER - A STUDY BY THE YORKSHIRE-REGIONAL-CANCER-ORGANIZATION THORACIC GROUP [J].

MUERS, MF ;

ROUND, CE .

THORAX, 1993, 48 (04) :339-343

[6]

Thomas Jay R, 2003, J Support Oncol, V1, P23

← 1 →